Growing Focus on Rare Disease Treatments Supporting Orphan Drugs Market Expansion
The global orphan drugs market was valued at USD 195.0 Bn in 2023 and is projected to experience steady growth over the coming years. The industry is expected to expand at a CAGR of 6.9% from 2024 to 2034, reaching USD 424.0 Bn by the end of 2034. The growth of the market is driven by increasing research and development activities for rare diseases, supportive government policies, and rising...
0 Comments 0 Shares 7 Views 0 Reviews